October 22, 2009
MOUNTAIN VIEW, Calif.
PRNewswire-FirstCall via COMTEX News Network-- Omnicell, Inc. (Nasdaq: OMCL), a leading provider of system solutions to acute healthcare facilities, today announced results for its third quarter ended September 30, 2009.
GAAP results: Revenue for the third quarter of 2009 was $54.0 million, up $1.3 million or 2.5% from the second quarter of 2009, and down $10.4 million or 16.1% from the third quarter of 2008.
Third quarter 2009 net income as reported in accordance with U.S. generally accepted accounting principles (GAAP) was $0.9 million, or $0.03 per diluted share. This compares to net income of $0.9 million, or $0.03 per diluted share in the second quarter of 2009 and net income of $2.9 million, or $0.09 per diluted share in the third quarter of 2008.
Non-GAAP results: Excluding the impact on our results of recording $2.4 million in stock-based compensation expense related to ASC 718, "Stock compensation" (formerly referred to as SFAS No. 123R), non-GAAP net income was $3.3 million for the third quarter of 2009, or $0.10 per diluted share. This compares to non-GAAP net income of $3.3 million, or $0.10 per diluted share for the second quarter of 2009, which excludes $2.4 million in stock compensation expense. Third quarter 2009 results compare to non-GAAP net income of $5.7 million, or $0.18 per diluted share for the third quarter of 2008.
"I am pleased with our performance in the third quarter," said Randall Lipps, Omnicell President, Chairman and CEO.
Read entire article.